HuMab-5B1 (MVT-5873), a mAb targeting sLe(a), in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies Meeting Abstract

  

Authors:	O'Reilly, E. M.; Borazanci, E. H.; Yu, K. H.; Varghese, A. M.; Estrella, H.; Kamins, D.; Melink, T.; Dorr, K.; Maffuid, P.; Gutheil, J.; Wang, J. S. Z.; Bauer, T. M.
Abstract Title:	HuMab-5B1 (MVT-5873), a mAb targeting sLe(a), in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies
Meeting Title:	54th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	36
Issue:	15 Suppl.
Meeting Dates:	2018 Jun 1-5
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2018-05-20
Language:	English
ACCESSION:	WOS:000442916005343
DOI:	10.1200/JCO.2018.36.15_suppl.e16235
PROVIDER:	wos
Notes:	Meeting Abstract: e16235 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/169564